Impressing Investors: How Regulatory Perks Can Power Rare Disease Research

 
• By Eliza Slawther
  
Dan Williams is CEO and co-founder of UK biotech SynaptixBio (SynaptixBio)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Interviews

More from Health Technology Assessment